Sign in

NCT03424343Completed

Longitudinal Identity Study of Childhood Cancer Survivors

The Long-term Impact of Pediatric Cancer on Adolescents, Emerging Adults, and Their Family: Identity, Psychosocial Functioning, and Development

Source: ClinicalTrials.gov · Last updated 20 Oct 2026

Brief summary (registry, in English)

The study investigators plan to conduct a longitudinal questionnaire study in adolescents and emerging adults (14-25 years of age at the start of the study) who survived childhood cancer to chart their identity development and broader social functioning. Additionally, the functioning of these survivors will be related to the functioning of their parents and siblings. The investigators shall focus especially on the current experience and impact of the earlier cancer experience. They will investigate to what extent the experience of a life-threatening disease has an effect on the daily life of survivors and over time and how the survivors develop through the course of adolescence and emerging adulthood on the psychosocial level. The formation of an adult identity is a very challenging task during adolescence and the way to adulthood and the fact that these youth had cancer during their childhood may especially complicate this process of identity formation. Furthermore, both parental and sibling functioning will be taken into account, which will allow us to examine inter-generational mechanisms (thus parental functioning that possibly impacts youth functioning and vice versa) and sibling functioning in these families. To investigate the latter, at each timepoint of the longitudinal study a sibling between 14 and 25 years of age at the start of the study will be included (if there is more than one sibling in a family, ideally the sibling who is closest in age will be the one who participates in the study). Moreover, a community sample that is matched on age and sex with the survivor of pediatric cancer will be assessed. This will allow the investigators to make well-founded comparisons regarding identity development and broader psychosocial functioning.

Status (registry)
Completed
Study type
Observational
Enrollment
126 (actual)
First submitted
29 Nov 2017
Start date
28 Aug 2018
Primary completion date
31 Dec 2024
Lead sponsor
KU Leuven
NCT number
NCT03424343

What you commit to

  • Study type: Observational
  • Participants enrolled: 126
  • From 28 Aug 2018 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Younger than 14 year and older than 25 year

Other

  • Mental retardation which hinders completion of the questionnaire bundle
  • Physically incapable to complete the questionnaire bundle
  • Insufficient knowledge of Dutch
  • Contact information is not available

Who the study is looking for

  • Survivors of childhood leukemia/lymphoma, solid tumors, and brain tumors, of whom the treatment has ended.
  • 14-25 years at the start of the study
  • Treated at the department of pediatric oncology at University Hospital Leuven, Belgium.
  • Sufficient knowledge of Dutch

Age in the registry: 14 years to 25 years · Sex: All

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gasthuisberg
Coordinator of this site? Confirm its status
LeuvenBelgiumUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.